Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 11/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 10/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2200726 | 0.91 | TLR7 (0.41) | ADORA2AADORA2BADORA3TLR7 | |
| SCHEMBL29809327 | 0.89 | TLR7 (0.47) | ADORA2AADORA2BTLR7 | |
| SCHEMBL2199802 | 0.89 | ADORA2A (0.43) | ADORA2AADORA2BADORA3TLR7 | |
| SCHEMBL567233 | 0.89 | TLR7 (0.47) | ADORA2AADORA2BTLR7 | |
| SCHEMBL10057869 | 0.89 | ADORA2A (0.37) | ADORA2AADORA2BADORA3TLR7 | |
| SCHEMBL2199990 | 0.88 | ADORA2A (0.42) | ADORA2AADORA2BADORA3TLR7 | |
| SCHEMBL2486847 | 0.88 | TLR7 (0.47) | ADORA2AADORA2BTLR7 | |
| SCHEMBL2199084 | 0.88 | TLR7 (0.37) | ADORA2AADORA2BADORA3TLR7 | |
| SCHEMBL2198756 | 0.87 | TLR7 (0.35) | ADORA2AADORA2BADORA3TLR7 | |
| SCHEMBL2198172 | 0.86 | ADORA2A (0.44) | ADORA2AADORA2BADORA3TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024199063-A1 | PHOSPHORUS OR SULFUR-CONTAINING MACROCYCLE AND USE THEREOF | 浙江养生堂天然药物研究所有限公司 | 2024-10-03 | — | — | WO | disclosed |
| CN-118724963-A | Macrocyclic compounds containing phosphorus or sulfur and use thereof | 浙江养生堂天然药物研究所有限公司 | 2024-10-01 | — | — | CN | disclosed |